Neurofibromatosis type 2 (NF2), a syndrome associated with multiple tumors of the nervous system, mostly schwannomas, is caused by mutations in the NF2 tumor suppressor gene that encodes schwannomin (Sch). Here we examined NF2 pathogenetic mutations that result in misfolding of the FERM domain. We found that these mutant forms of Sch were efficiently degraded by the ubiquitin-proteasome pathway. In transfected cells, Sch⌬F118 was 3-fold more efficiently degraded than the related molecule ezrin bearing the equivalent mutation. In heterozygous Nf2 knock-out mouse fibroblasts, endogenous mutant Sch⌬81-121, but not wild type Sch, was also degraded by proteasomes. We further show that this degradation pathway is functional in primary Schwann cells. We analyzed Sch⌬39 -121 expressed in a transgenic mouse model of NF2 and found that Sch⌬39 -121, but not the endogenous wild type Sch, was unstable due to proteasome-mediated degradation. Altogether these results suggest that degradation of mutant Sch mediated by the ubiquitin-proteasome pathway is a physiopathological pathway contributing to the loss of Sch function in NF2 patients.
Neurofibromatosis type 2 (NF2)1 is a dominantly inherited disorder characterized by the predisposition to develop multiple nervous system tumors, in particular schwannomas. Tumor development in NF2 patients is in accordance with Knudson's two-hit hypothesis for tumor suppressor genes. As NF2 patients inherit one mutant NF2 allele, a second hit in the remaining wild type allele is sufficient to induce tumorigenesis. The two NF2 alleles are also inactivated in the majority of sporadic schwannomas (1).The NF2 tumor suppressor gene product, Schwannomin (Sch), also known as merlin, displays 45% identity with ERM proteins, which are cytoskeletal linkers between cortical actin filaments and the plasma membrane (2, 3). Like ERM proteins, Sch has an amino-terminal FERM domain and a carboxylterminal domain that associate in an intramolecular manner to form closed monomers and in an intermolecular manner to form oligomers (4 -6). The FERM domain of Sch binds to the plasma membrane and to filamentous actin (7,8). Sch regulates cell adhesion and motility (9, 10) and mediates contact inhibition (11).In human tumors, levels of mutant Sch are consistently below limits of detection although NF2 mutant alleles were detected at the mRNA level (12-15). Therefore, we reasoned that mutant schwannomin might be degraded quickly. To examine this hypothesis, we studied the stability of mutant schwannomin in transfected cells or in primary cultures derived from mouse models developed to examine the pathogenesis of NF2 (16, 17). We focused on pathogenetic mutations in the conserved FERM domain of Sch. The deletion of the phenylalanine 118 codon in exon 3 has been described in two unrelated families affected by NF2 as well as in a sporadic meningioma (Ref. 12 and references therein). Mutations that lead to the skipping of exon 3 (Sch⌬81-121) or exons 2-3 (Sch⌬39 -121) have been observed in the germ line or in the tumors o...